PET TOR Week ended 07 Aug 2026

Weekly Investor Report

Pet Valu Holdings Ltd. · Consumer Cyclical · Specialty Retail

Open interactive chart View report data
Latest close 18.88 CAD
-3.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -13.4% below the Trend Line and sits at 10.9% of its 52-week range. The latest completed week returned -3.8%, after a 0.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal.

Setup score 34 out of 100
Latest Close 18.88 CAD 7 Aug 2026
1W Return -3.8% latest completed week
4W Return 0.3% short-term follow-through
12W Return 7.6% quarterly tape
Trend Breadth 23.1% 12 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.8% Latest completed week; four-week move 0.3%. Indicator stack 13/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 58/100 2 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -13.4% below the Trend Line and sits at 10.9% of its 52-week range. The latest completed week returned -3.8%, after a 0.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1412-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.3% over four weeks, 7.6% over 12 weeks, and -46.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-3.8%
4W0.3%
12W7.6%
26W-34.2%
52W-46.4%
Active trend streak0 weeks
Active weeks in one year12
Trend breadth23.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.54Latest activity-pressure read.
Pressure change990.5%Four-week change in activity pressure.
Leadership-37.36Latest relative-leadership reading.
RS change5.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength73/100Blend of value, momentum, and quality. Underlying universe rank 28; rank 1 is best.
Value73/100Relative valuation strength. Underlying universe rank 28; rank 1 is best.
Quality94/100Profitability and accounting quality. Underlying universe rank 7; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth67/100Revenue and earnings growth. Underlying universe rank 34; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework77/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
13.2x
Price divided by trailing earnings.
Price / sales
1.1x
Market value relative to trailing revenue.
EV / EBITDA
8.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
33.1%
Gross profit retained from each unit of revenue.
Operating margin
14.0%
Operating profit retained from revenue.
Free-cash-flow margin
12.2%
Free cash flow generated from revenue.
Return on invested capital
14.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.1%
Latest one-year revenue growth.
EPS growth
14.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
7.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.6%
Cash dividends relative to market value.
Buyback yield
6.8%
Net share repurchases relative to market value.
Shareholder yield
9.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment58/100

Weighted news tone is positive across 2 relevant articles.

1 positive · 1 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-51.0%Distance below the 52-week high.
13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+5.5%Week of 29 May.
Worst week-14.6%Week of 6 Mar.
Latest week-3.8%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains5
Flat weeks0
Modest losses12
Sharp losses5
Recent vol4.6%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape31/100

Trend, activity pressure, participation, and risk combine to a 31/100 tape read.

 Indicator analysis20/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.14; No reversal markers Factors62/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 5; Small Cap Core rank 22 SVQF77/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 70.5 of 304 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment58/100

Weighted news tone is positive across 2 relevant articles.

Pet Valu (TSX:PET) Lifts Earnings And Maintains Dividend Is Its Capital Allocation Strategy Evolving? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202618.88 CAD-3.8%21.80 CAD26.61 CAD0.54-37.36693.7KOff
31 Jul 202619.63 CAD5.0%22.09 CAD26.64 CAD0.50-33.89950.2KOff
24 Jul 202618.70 CAD-3.0%22.34 CAD26.70 CAD0.35-38.19856.4KOff
17 Jul 202619.28 CAD2.4%22.64 CAD26.77 CAD0.20-37.04922.0KOff
10 Jul 202618.82 CAD-0.4%22.93 CAD26.82 CAD0.05-39.52729.1KOff
3 Jul 202618.89 CAD4.1%23.26 CAD26.89 CAD-0.18-40.0962.7KOff
26 Jun 202618.15 CAD0.4%23.58 CAD26.95 CAD-0.57-42.83219.2KOff
19 Jun 202618.08 CAD-4.6%23.92 CAD27.02 CAD-0.81-43.842.0MOff
12 Jun 202618.96 CAD1.7%24.24 CAD27.09 CAD-1.17-41.86486.4KOff
5 Jun 202618.64 CAD-0.1%24.54 CAD27.15 CAD-1.27-42.70138.4KOff
29 May 202618.65 CAD5.5%24.84 CAD27.22 CAD-1.19-43.961.4MOff
22 May 202617.69 CAD0.8%25.36 CAD27.29 CAD-1.21-47.05959.4KOff
15 May 202617.55 CAD-12.4%25.94 CAD27.38 CAD-1.16-47.133.4MOff
8 May 202620.03 CAD-3.8%26.53 CAD27.47 CAD-1.15-40.74806.4KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context